Palisade Bio (PALI) Cash from Investing Activities (QoQ) (2010 - 2020)
Powered by 
Analysis
Palisade Bio (PALI) Cash from Investing Activities (QoQ) (2010 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -200.00% |
| Mar 31, 2018 | 1,225,590.20% |
| Dec 31, 2017 | -114.74% |
| Jun 30, 2016 | -101.35% |
| Mar 31, 2016 | 393.27% |
| Dec 31, 2015 | -125.56% |
| Sep 30, 2015 | 10,852.44% |
| Jun 30, 2015 | 5.45% |
| Mar 31, 2015 | -29.24% |
| Dec 31, 2014 | 20.03% |
| Sep 30, 2014 | 43.91% |
| Jun 30, 2014 | 98.89% |
| Mar 31, 2014 | -16,387.95% |
| Dec 31, 2013 | 55.42% |
| Sep 30, 2013 | -47.11% |
| Jun 30, 2013 | -45.42% |
| Mar 31, 2013 | -45.50% |
| Dec 31, 2012 | -72.27% |
| Sep 30, 2012 | 68.06% |
| Jun 30, 2012 | -320.34% |